Why Only 1 in 4 People with ALS Can Realistically Access Clinical trials

Table of Contents Introduction Key findings at a glance Most people with ALS had trial options – so why is enrollment so low? The ALS trial access funnel: where patients drop off Why do people living with ALS lose trial eligibility so quickly? What are the biggest barriers to ALS clinical trial access?